Astera Labs, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
ALAB
Astera Labs, INCSCHEDULE: BlackRock Discloses Astera Labs Stake
BlackRock, Inc. has updated its Schedule 13G filing, reporting a beneficial ownership of 7.4% in Astera Labs Inc. as of June 30, 2026.
NASDAQ
ALAB
Astera Labs, INCThe Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership of Astera Labs Inc. Common Stock following an internal realignment.
NASDAQ
ALAB
Astera Labs, INCSCHEDULE 13G/A: BlackRock Boosts Astera Labs Stake to 6.2%
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 6.2% of Astera Labs Inc.'s common stock as of December 31, 2025.
NASDAQ
ALAB
Astera Labs, INCSanjay Gajendra, a U.S. citizen, has reported beneficial ownership of 4.5% of Astera Labs, Inc.'s common stock as of September 30, 2025.
NASDAQ
ALAB
Astera Labs, INCSCHEDULE: Astera Labs Insider Discloses 5.4% Stake
Jitendra Mohan, an individual, reported beneficial ownership of 5.4% of Astera Labs, Inc.'s common stock as of September 30, 2025.
NASDAQ
ALAB
Astera Labs, INCSCHEDULE 13G: BlackRock Discloses 5.02% Stake in Astera Labs
BlackRock, Inc. has reported a beneficial ownership of 5.02% of Astera Labs Inc.'s common stock, totaling 8,352,673 shares.
NASDAQ
ALAB
Astera Labs, INCAllianceBernstein L.P. reported a 3.9% beneficial ownership stake in Astera Labs Inc. common stock, held for investment purposes.
NASDAQ
ALAB
Astera Labs, INCThe Vanguard Group has reported a 7.3% beneficial ownership stake in Astera Labs Inc., holding over 12 million shares of common stock.
NASDAQ
ALAB
Astera Labs, INCAllianceBernstein L.P. has filed a Schedule 13G, revealing a beneficial ownership of 5.2% in Astera Labs Inc.'s common stock as of March 31, 2025.
NASDAQ
ALAB
Astera Labs, INCSCHEDULE 13G/A: Atreides Management Discloses 1.2% Passive Stake in Astera Labs
Atreides Management, LP, along with its affiliates, has filed an amended Schedule 13G disclosing a passive beneficial ownership of 1.2% in Astera Labs, Inc.
NASDAQ
ALAB
Astera Labs, INCThe Vanguard Group has reported a 5.8% beneficial ownership stake in Astera Labs Inc., holding over 9.2 million shares as a passive investment.